Zentiva Private Limited — Rivaroxaban Exporter Profile
Indian Pharmaceutical Exporter · #3 for Rivaroxaban · $3.2M export value · DGFT Verified
Zentiva Private Limited is the #3 Indian exporter of Rivaroxaban with $3.2M in export value and 148 verified shipments. Zentiva Private Limited holds a 6.1% market share in Rivaroxaban exports across 2 countries. The company exports 8 pharmaceutical products worth $62.4M across 4 therapeutic categories.
Zentiva Private Limited — Rivaroxaban Export Profile: Buyers & Destinations
Where Does Zentiva Private Limited Export Rivaroxaban?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $2.8M | 129 | 96.2% |
| SWITZERLAND | $108.2K | 19 | 3.8% |
Zentiva Private Limited exports Rivaroxaban to 2 countries. The largest destination is MALTA accounting for 96.2% of Zentiva Private Limited's Rivaroxaban shipments. These destinations reflect Zentiva Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rivaroxaban from Zentiva Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMADOX HEALTHCARE LTD | MALTA | $2.0M | 94 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $726.1K | 35 |
| HELVEPHARM AG | SWITZERLAND | $108.2K | 19 |
Zentiva Private Limited supplies Rivaroxaban to 3 buyers globally. The largest buyer is PHARMADOX HEALTHCARE LTD (MALTA), followed by PHARMADOX HEALTHCARE LIMITED (MALTA) and HELVEPHARM AG (SWITZERLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rivaroxaban Export Value and How Much Does Zentiva Private Limited Contribute?
India exported $36.7M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. Zentiva Private Limited contributes $3.2M to this total, accounting for 6.1% of India's Rivaroxaban exports. Zentiva Private Limited ships Rivaroxaban to 2 countries through 3 buyers.
What Is the Average Shipment Value for Zentiva Private Limited's Rivaroxaban Exports?
Zentiva Private Limited's average Rivaroxaban shipment value is $21.5K per consignment, based on 148 shipments totaling $3.2M. The largest destination is MALTA (96.2% of Zentiva Private Limited's Rivaroxaban exports).
How Does Zentiva Private Limited Compare to Other Indian Rivaroxaban Exporters?
Zentiva Private Limited ranks #3 among 221 Indian Rivaroxaban exporters with a 6.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($12.8M), DR.REDDY'S LABORATORIES LTD ($5.2M), ZENTIVA PRIVATE LIMITED ($3.2M). Zentiva Private Limited processed 148 shipments to 2 destination countries.
What Rivaroxaban Formulations Does Zentiva Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FR (51772 PCS)PCS | $152.7K | 6 |
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FR (104895 PIECES)PCS | $143.7K | 3 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN 20MG TABCO BL7X14 M24 DE ZMID CODE: 938898PCS | $141.4K | 3 |
| RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FRZMID CODE: 938876- PHARAMACEUTICAL PRODUCTS | $132.6K | 3 |
| PHARAMACEUTICAL PRODUCTS, RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FR, ZMID CODE: 938876 | $132.2K | 3 |
| RIVAROXABAN 20MG TABCO BL2X14 M24 GB ZMID CODE: 938938 ,PHARAMACEUTICAL PRODUCTS | $109.4K | 3 |
| PHARAMACEUTICAL PRODUCTS, RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FR ZMID Code: 938876 | $106.2K | 3 |
| RIVAROXABAN ZTV 15MG TABCO BL2X14 M24 FRPHARAMACEUTICAL PRODUCTS | $92.0K | 4 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN 20MG TABCO BL7X14 M24 DE ZMID CODE: 938898 | $76.2K | 2 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 PT ZMID CODE: 938087PCS | $73.3K | 3 |
Zentiva Private Limited exports 104 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 with 6 shipments worth $152.7K.
How Does Zentiva Private Limited Compare to Nearest Rivaroxaban Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $12.8M | 257 | 11 | $50.0K |
| 2 | DR.REDDY'S LABORATORIES LTD | $5.2M | 131 | 12 | $39.6K |
| 3 | ZENTIVA PRIVATE LIMITED ★ | $3.2M | 148 | 2 | $21.5K |
| 5 | MICRO LABS LIMITED | $2.4M | 141 | 20 | $16.9K |
| 6 | APOTEX RESEARCH PRIVATE LIMITED | $2.3M | 54 | 1 | $42.1K |
Zentiva Private Limited ranks #3 among 221 Indian Rivaroxaban exporters. Average shipment value of $21.5K compared to the market average of $166.0K. The closest competitors by value are MYLAN LABORATORIES LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Rivaroxaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,144 | 21.3% |
| DELHI AIR CARGO ACC (INDEL4) | 985 | 18.4% |
| DELHI AIR | 659 | 12.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 635 | 11.8% |
| Bombay Air | 197 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 164 | 3.1% |
| Delhi Air | 133 | 2.5% |
| HYDERABAD AIR | 110 | 2.1% |
What Other Cardiovascular Products Does Zentiva Private Limited Export?
Zentiva Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Zentiva Private Limited's Rivaroxaban Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zentiva Private Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for exporters relying on these routes. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries.
Conversely, the evolving trade dynamics between the U.S. and China have opened avenues for Indian pharmaceutical companies. As the U.S. seeks to diversify its supply chains, Indian exporters are well-positioned to fill the gap, provided they meet stringent regulatory standards. Additionally, the India–European Union Free Trade Agreement, signed in January 2026, aims to eliminate tariffs on pharmaceutical products, enhancing market access for companies like Zentiva. (en.wikipedia.org)
Zentiva Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Zentiva's manufacturing facility in Ankleshwar adheres to Good Manufacturing Practices (GMP), ensuring product quality and safety. The company's commitment to regulatory compliance is further evidenced by its strategic partnerships, such as the licensing agreement with Lupin for the biosimilar Certolizumab Pegol, which involves joint investment in development and adherence to regulatory milestones. (business-standard.com)
The European Union's Falsified Medicines Directive imposes stringent requirements on pharmaceutical imports, necessitating robust serialization and traceability measures. Zentiva's proactive approach to these regulations enhances its credibility and facilitates smoother market entry into the EU.
About Zentiva Private Limited
Zentiva Private Limited exports 8 products worth $62.4M. Beyond Rivaroxaban, top products include Metformin, Clopidogrel, Paracetamol, Ramipril, Fexofenadine. View the complete Zentiva Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zentiva Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 148 individual customs records matching Zentiva Private Limited exporting Rivaroxaban, covering 104 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Export Data from Zentiva Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zentiva Private Limited's Rivaroxaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zentiva Private Limited
Full Company Profile →
8 products · $62.4M total trade · 4 categories
Rivaroxaban Stats
Company Overview
Top Products by Zentiva Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zentiva Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current shipment-level data, contact TransData Nexus.